about
Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay.Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2Targeting membrane proteins for antibody discovery using phage display.Nanoyeast and Other Cell Envelope Compositions for Protein Studies and Biosensor Applications.Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10.Nanocell targeting using engineered bispecific antibodies.Computational Identification of Antibody Epitopes on the Dengue Virus NS1 Protein.CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.A concise review of nanoscopic aspects of bioleaching bacteria-mineral interactions.Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.Safety of biologics therapy: Monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxins.Cell-free pipeline for discovery of thermotolerant xylanases and endo-1,4-β-glucanases.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.Insights into the interfacial structure-function of poly(ethylene glycol)-decorated peptide-stabilised nanoscale emulsions.Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.Biosensing made easy with PEG-targeted bi-specific antibodies.Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach.Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies.Biosimilars approved for treatment of inflammatory rheumatological diseases.Selection of Antibodies to Transiently Expressed Membrane Proteins Using Phage DisplayMultiplexed SERS Detection of Soluble Cancer Protein Biomarkers with Gold-Silver Alloy Nanoboxes and Nanoyeast Single-Chain Variable FragmentsInnovative Therapeutic Strategies for Effective Treatment of Brain MetastasesRetooling phage display with electrohydrodynamic nanomixing and nanopore sequencingWavelength-Dependent Fluorescent Immunosensors via Incorporation of Polarity Indicators near the Binding Interface of Antibody FragmentsModulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesAttenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical productionMultifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy
P50
Q33880750-E0932670-A6CF-40E4-9296-07ABCBFD81F6Q33997700-19B5A2E0-2E73-4724-8A5A-0205847746FEQ36020577-90004047-D886-43AA-9189-8AFCB6B2FEEDQ36168796-10EAB38E-8301-4C67-A61C-076994823E53Q36200871-0B13CD09-DFED-418D-9898-4FED7542F398Q36211456-57F26F95-D168-40A5-8A0D-43E153B5A574Q36342001-9CBCE034-1844-497F-B131-078A7F3F2EA7Q37078990-DD7F6C3A-3C97-4819-B21E-6F6E03AF2777Q38253208-D670C7B2-D3B2-4211-9744-9D0C03EE18A6Q41045557-F9ECA39A-1112-4A7A-A2DB-84336C8A7D8FQ41210681-2286F054-DBD0-46A2-9156-FBFC824D5830Q43031529-DBA19999-4A10-4143-9034-BB8B244A194CQ47107902-28ED6BB7-5BAA-4F6A-A74C-F030BE9ABAFDQ47725919-D20D1A20-6017-48A8-8A04-7B513707ED17Q47840214-A4B275B5-1881-4ABA-8428-A0EC1FC675EAQ50048109-7C22006D-BD2C-489A-9D51-53988E921028Q51297471-BEC6E3B4-52E5-46CB-A99C-9B42047EF107Q51393032-5E50484E-ACE8-487B-B437-D2EE0481D476Q52323683-9DD1E622-F662-417C-A564-61C9E28B9F88Q53565685-7872F458-89DF-4028-BE9D-6E3E1518EE5BQ53604274-7259A1EB-8BEF-4FD4-8E66-A042AE66957FQ56889731-9465D49E-B8D1-4467-B095-2ACF049E3927Q57132638-DE73A11B-89FE-4AB9-8C9A-074A19D103D2Q64093580-03D5CEC6-B593-4FDC-9BD4-CE1C50325D48Q91236390-2F5D72F9-06CD-456E-8568-B72AEBF0CA71Q92220396-157A1F13-90DE-43F4-96FE-00AE6DAC5A7AQ92348910-0C15691F-CE04-40AF-B0BA-BD99369498E0Q92596627-CD6CE39F-14CF-41B1-86B7-86BCFEA960D6Q92721639-A35DA6EC-696A-44BF-886C-6E77BF1F38CC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
S M Mahler
@en
S M Mahler
@nl
type
label
S M Mahler
@en
S M Mahler
@nl
prefLabel
S M Mahler
@en
S M Mahler
@nl
P31
P496
0000-0003-2403-1437